CLB - Core Laboratories N.V.
NEXT EARNINGS:
Apr 29, 2026
EPS Est: $0.15
|
Rev Est: $125.4M
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$25.00
DETAILS
HIGH:
$32.00
LOW:
$17.00
MEDIAN:
$26.00
CONSENSUS:
$25.00
UPSIDE:
42.29%
Market Cap:
818.12M
Volume:
662,481
Avg Volume:
373,723
52 Week Range:
9.72-20.36
Sector:
Energy
Industry:
Oil & Gas Equipment & Services
Beta:
1.09
Last Dividend:
$0.04
Exchange:
NYSE
Country:
NL
Employees:
3,400
IPO Date:
1995-09-21
EPS (TTM):
0.68
P/E Ratio:
23.44
Revenue (TTM):
526.52M
Total Assets:
596.95M
Total Debt:
206.33M
Cash & Equiv:
22.85M
Rev Growth (5Y):
1.6%
EPS Growth (5Y):
-8.1%
FCF Growth (5Y):
-13.3%
ROCE:
10.0%
Debt/Equity:
0.74
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-04 | $0.21 | $0.20 | +5.0% | $138.3M | $125.4M | +10.3% |
| 2025-10-22 | $0.22 | $0.19 | +15.8% | $134.5M | $128.6M | +4.6% |
| 2025-07-23 | $0.19 | $0.18 | +5.6% | $130.2M | $130.9M | -0.6% |
| 2025-04-23 | $0.14 | $0.15 | -6.7% | $123.6M | $128.9M | -4.1% |
| 2025-01-29 | $0.22 | $0.23 | -4.3% | $129.2M | $125.1M | +3.3% |
| 2024-10-23 | $0.25 | $0.23 | +8.7% | $134.4M | $134.0M | +0.3% |
| 2024-07-24 | $0.22 | $0.21 | +4.8% | $130.6M | $134.3M | -2.8% |
| 2024-04-24 | $0.19 | $0.16 | +18.8% | $129.6M | $124.1M | +4.4% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 526.52M | 523.85M | 509.79M | 489.74M | 470.25M | 487.27M | 668.21M | 700.85M | 659.81M | 594.74M | 797.52M | 1.09B |
| Net Income | 31.80M | 31.40M | 36.67M | 19.45M | 19.73M | (97.64M) | 101.98M | 79.53M | 83.12M | 63.90M | 114.85M | 257.49M |
| EPS | 0.68 | 0.67 | 0.79 | 0.42 | 0.43 | -2.18 | 2.11 | 1.80 | 1.88 | 1.45 | 2.71 | 5.90 |
| Total Assets | 596.95M | 590.41M | 586.39M | 578.35M | 580.85M | 568.58M | 774.67M | 648.83M | 584.81M | 573.05M | 625.26M | 675.65M |
| Total Debt | 206.33M | 180.14M | 215.38M | 222.39M | 250.26M | 326.98M | 381.78M | 289.77M | 226.99M | 216.49M | 430.99M | 356.00M |
| Cash & Equivalents | 22.85M | 19.16M | 15.12M | 15.43M | 17.70M | 13.81M | 11.09M | 13.12M | 14.40M | 14.76M | 22.49M | 23.35M |
| Operating Cash Flow | 37.18M | 56.39M | 24.79M | 24.96M | 36.58M | 57.87M | 89.53M | 111.83M | 124.27M | 131.89M | 219.10M | 303.45M |
| Free Cash Flow | 22.59M | 43.36M | 14.21M | 14.74M | 23.04M | 45.99M | 67.26M | 90.09M | 105.50M | 120.18M | 194.84M | 266.01M |
| FCF per Share | 0.49 | 0.92 | 0.30 | 0.32 | 0.50 | 1.03 | 1.52 | 2.04 | 2.39 | 2.76 | 4.60 | 6.10 |
| Book Value | 279.76M | 251.99M | 224.81M | 184.26M | 156.45M | 71.51M | 177.87M | 160.90M | 148.73M | 155.30M | (23.70M) | 93.99M |
| Cash & ST Investments | 22.85M | 19.16M | 15.12M | 15.43M | 17.70M | 13.81M | 11.09M | 13.12M | 14.40M | 14.76M | 22.49M | 23.35M |
| ROC Equity | 0.11 | 0.12 | 0.16 | 0.11 | 0.13 | -1.37 | 0.57 | 0.49 | 0.56 | 0.41 | N/A | 2.74 |